Cargando…

Bevacizumab in recurrent glioblastoma

Detalles Bibliográficos
Autores principales: Martinez, Nina L., Glass, Jon, Shi, Wenyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797887/
https://www.ncbi.nlm.nih.gov/pubmed/35117090
http://dx.doi.org/10.21037/tcr.2018.12.33
_version_ 1784641662052466688
author Martinez, Nina L.
Glass, Jon
Shi, Wenyin
author_facet Martinez, Nina L.
Glass, Jon
Shi, Wenyin
author_sort Martinez, Nina L.
collection PubMed
description
format Online
Article
Text
id pubmed-8797887
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87978872022-02-02 Bevacizumab in recurrent glioblastoma Martinez, Nina L. Glass, Jon Shi, Wenyin Transl Cancer Res Editorial AME Publishing Company 2019-03 /pmc/articles/PMC8797887/ /pubmed/35117090 http://dx.doi.org/10.21037/tcr.2018.12.33 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Editorial
Martinez, Nina L.
Glass, Jon
Shi, Wenyin
Bevacizumab in recurrent glioblastoma
title Bevacizumab in recurrent glioblastoma
title_full Bevacizumab in recurrent glioblastoma
title_fullStr Bevacizumab in recurrent glioblastoma
title_full_unstemmed Bevacizumab in recurrent glioblastoma
title_short Bevacizumab in recurrent glioblastoma
title_sort bevacizumab in recurrent glioblastoma
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797887/
https://www.ncbi.nlm.nih.gov/pubmed/35117090
http://dx.doi.org/10.21037/tcr.2018.12.33
work_keys_str_mv AT martinezninal bevacizumabinrecurrentglioblastoma
AT glassjon bevacizumabinrecurrentglioblastoma
AT shiwenyin bevacizumabinrecurrentglioblastoma